Evidence map›Paper›PMID 40439345›Full record

ReviewImmunological reviews2025

Thymic Interferons: A Little Goes a Long Way.

Matouš Vobořil, Kristin A Hogquist

Abstract readReview
In one paragraph

Review in Immunological reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Thymic Dendritic Cells Revisited.Immunological reviews · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Matouš VobořilDepartment of Lab Medicine and Pathology, Center for Immunology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Kristin A HogquistDepartment of Lab Medicine and Pathology, Center for Immunology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0001-9963-5687

Funding

Type I interferons in tolerance in the steady stateP01AI035296 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI FIFE, BRIAN T · 1993 to 2023
$31.1M
TCR signaling in thymic selection: Role of innate immune activationR01AI179749 · NIAID · UNIVERSITY OF MINNESOTA · PI Kristin A. Hogquist · 2024 to 2026
$1.9M
NIAID NIH HHS P01 AI035296NIAID NIH HHS R01 AI179749NIH HHS P01 AI35296NIH HHS R01 AI179479
6 · The paper itself

Abstract

Central tolerance is an essential process that protects the mammalian immune system from developing autoimmune reactions by forming a self-tolerant repertoire of T cells. The extent of central tolerance depends on the diversity of self-peptide-major histocompatibility complexes that thymocytes encounter on thymic antigen-presenting cells (APCs). Decades of research have demonstrated that medullary thymic epithelial cells (mTECs), a unique type of APC of stromal origin, possess an extraordinary capacity to produce and present thousands of self-peptides to developing thymocytes. This ability is facilitated by various unconventional mechanisms, including AIRE-regulated promiscuous gene expression, mimicry of peripheral cell types, and cooperative antigen transfer between different thymic APCs. Recently, several studies have reported that mTECs and other thymus-resident cells also produce tonic inflammatory signaling, which shapes the thymic microenvironment and expands the repertoire of presented inflammation-associated self-antigens (ISA). In this review, we focus on thymic interferons (IFNs), pro-inflammatory molecules produced as self-antigens by mTECs. Beyond their role as rare self-antigens critical for tolerance induction, IFNs influence the thymic microenvironment by promoting sterile inflammation, regulating the maturation of thymic APCs, and shaping T cell selection. We will discuss the production and regulation of thymic IFNs and their role in APC maturation and T cell selection.

Indexed as

Antigen-Presenting CellsInterferonsThymus GlandT-LymphocytesAnimalsAntigen PresentationAutoantigensCentral ToleranceEpithelial CellsHumansSignal TransductionAutoantigensInterferonsantigen‐presenting cellsinterferoninterferon‐stimulated genesT cell selectionthymus

Identifiers

PMID40439345
PMCPMC12140175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.